Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 328-334 , June 2010

The role of the ‘innovative therapies for children with cancer’ (ITCC) European consortium

  • C. Michel Zwaan

      Affiliations

    • Dept. of Ped Oncology/Hematology, Erasmus MC/Sophia Children’s Hospital, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
    • Corresponding Author InformationCorresponding author. Address: Dept. of Ped Oncology/Hematology, Erasmus MC/Sophia Children’s Hospital, Dr. Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands. Tel.: +31 10 703 6691; fax: +31 10 703 1134.
  • ,
  • Pamela Kearns

      Affiliations

    • Institute for Cancer Studies, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Huib Caron

      Affiliations

    • Dept. of Ped Oncology/Hematology, Academic Medical Centre/Emma Children’s Hospital, Amsterdam, The Netherlands
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Arnauld Verschuur

      Affiliations

    • Dept. of Ped Oncology/Hematology, Academic Medical Centre/Emma Children’s Hospital, Amsterdam, The Netherlands
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Riccardo Riccardi

      Affiliations

    • Division of Ped Oncology, Università Cattolica di Roma, Policlinico Universitario A. Gemelli, Rome, Italy
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Joachim Boos

      Affiliations

    • Dept. of Ped Haematology and Oncology, University Children’s Hospital Münster, Münster, Germany
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Francois Doz

      Affiliations

    • Dept. of Ped Oncology, Institute Curie, Paris, France
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Birgit Geoerger

      Affiliations

    • Division of Ped Oncology, Università Cattolica di Roma, Policlinico Universitario A. Gemelli, Rome, Italy
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Bruce Morland

      Affiliations

    • Institute for Cancer Studies, School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • Gilles Vassal

      Affiliations

    • Division of Ped Oncology, Università Cattolica di Roma, Policlinico Universitario A. Gemelli, Rome, Italy
    • Dept. of Ped Oncology, Institute Gustave Roussy, Villejuif, France
  • ,
  • On behalf of the ‘innovative therapies for children with cancer’ European consortium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00028-9

doi: 10.1016/j.ctrv.2010.02.008

Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 328-334 , June 2010